U.S. flag

An official website of the United States government

NM_016495.6(TBC1D7):c.322dup (p.Tyr108fs) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jul 5, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002958097.2

Allele description [Variation Report for NM_016495.6(TBC1D7):c.322dup (p.Tyr108fs)]

NM_016495.6(TBC1D7):c.322dup (p.Tyr108fs)

Genes:
TBC1D7:TBC1 domain family member 7 [Gene - OMIM - HGNC]
TBC1D7-LOC100130357:TBC1D7-LOC100130357 readthrough [Gene]
Variant type:
Duplication
Cytogenetic location:
6p24.1
Genomic location:
Preferred name:
NM_016495.6(TBC1D7):c.322dup (p.Tyr108fs)
HGVS:
  • NC_000006.12:g.13320967dup
  • NG_033862.1:g.12617dup
  • NM_001143964.4:c.322dup
  • NM_001143965.4:c.322dup
  • NM_001143966.4:c.241dup
  • NM_001258457.3:c.322dup
  • NM_001318805.2:c.322dup
  • NM_001318806.2:c.241dup
  • NM_001318809.2:c.322dup
  • NM_016495.6:c.322dupMANE SELECT
  • NP_001137436.1:p.Tyr108fs
  • NP_001137437.1:p.Tyr108fs
  • NP_001137438.1:p.Tyr81fs
  • NP_001245386.1:p.Tyr108fs
  • NP_001305734.1:p.Tyr108fs
  • NP_001305735.1:p.Tyr81fs
  • NP_001305738.1:p.Tyr108fs
  • NP_057579.1:p.Tyr108fs
  • NC_000006.11:g.13321198_13321199insA
  • NC_000006.11:g.13321199dup
  • NM_001143965.4:c.322dupT
  • NR_134872.2:n.412dup
Protein change:
Y108fs
Molecular consequence:
  • NM_001143964.4:c.322dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001143965.4:c.322dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001143966.4:c.241dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001258457.3:c.322dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001318805.2:c.322dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001318806.2:c.241dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001318809.2:c.322dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_016495.6:c.322dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_134872.2:n.412dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003272782Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jul 5, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly.

Capo-Chichi JM, Tcherkezian J, Hamdan FF, Décarie JC, Dobrzeniecka S, Patry L, Nadon MA, Mucha BE, Major P, Shevell M, Bencheikh BO, Joober R, Samuels ME, Rouleau GA, Roux PP, Michaud JL.

J Med Genet. 2013 Nov;50(11):740-4. doi: 10.1136/jmedgenet-2013-101680. Epub 2013 May 17.

PubMed [citation]
PMID:
23687350

TBC1D7 mutations are associated with intellectual disability, macrocrania, patellar dislocation, and celiac disease.

Alfaiz AA, Micale L, Mandriani B, Augello B, Pellico MT, Chrast J, Xenarios I, Zelante L, Merla G, Reymond A.

Hum Mutat. 2014 Apr;35(4):447-51. doi: 10.1002/humu.22529.

PubMed [citation]
PMID:
24515783
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003272782.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Tyr108Leufs*24) in the TBC1D7 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TBC1D7 are known to be pathogenic (PMID: 23687350, 24515783). This variant is present in population databases (rs758759342, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with TBC1D7-related conditions. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024